Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 5 filers reported holding Santen Pharmaceutical Co Ltd in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,000 | 0.0% | 518 | -3.9% | 0.00% | – |
| Q1 2021 | $7,000 | -30.0% | 539 | -13.8% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 625 | +8.7% | 0.00% | – |
| Q3 2020 | $12,000 | +9.1% | 575 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 575 | -12.5% | 0.00% | – |
| Q1 2020 | $11,000 | -8.3% | 657 | +3.5% | 0.00% | – |
| Q4 2019 | $12,000 | +71.4% | 635 | +62.8% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 390 | -8.7% | 0.00% | – |
| Q2 2019 | $7,000 | 0.0% | 427 | -6.8% | 0.00% | – |
| Q1 2019 | $7,000 | 0.0% | 458 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -22.2% | 458 | -22.6% | 0.00% | – |
| Q3 2018 | $9,000 | -25.0% | 592 | -15.2% | 0.00% | – |
| Q2 2018 | $12,000 | +20.0% | 698 | +15.4% | 0.00% | – |
| Q1 2018 | $10,000 | 0.0% | 605 | -2.9% | 0.00% | – |
| Q4 2017 | $10,000 | 0.0% | 623 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | +42.9% | 623 | +27.1% | 0.00% | – |
| Q2 2017 | $7,000 | 0.0% | 490 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | +133.3% | 490 | +105.9% | 0.00% | – |
| Q4 2016 | $3,000 | -62.5% | 238 | -56.6% | 0.00% | – |
| Q3 2016 | $8,000 | -11.1% | 548 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +80.0% | 548 | +76.8% | 0.00% | – |
| Q1 2016 | $5,000 | – | 310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | $273 | 0.00% |